Sunshine Law Stalls

The CME and pharmaceutical industries received a reprieve when the U.S. Senate failed to take up the Physician Payments Sunshine Act in 2007. But it is likely to be up for a vote in 2008, cautions Thomas P. Sullivan, president, Rockpointe Corp., Columbia, Md.

The bill would require pharmaceutical and medical device manufacturers to disclose payments they make to doctors directly, indirectly, or through a third party, including gifts, honoraria, travel, and CME. The information would b

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish